Focus on the patient-reported outcome of patients with chronic myeloid leukemia
JIANG Qian
Abstract：Successful use of tyrosine kinase inhibitors prolongs survival of patients with chronic myeloid leukemia and make it dose to normal population.In clinical practice,there is a lot of important information that can only be learned from the patient.Therefore,integrating patient-reported outcome (PRO) into clinical trial and clinical practice has become one of academic concerns.Definition and research of PRO in CML will be reviewed in this paper.
Keywords：chronic myeloid leukemiapatient-reported outcometyrosine-kinase inhibitor
Publication Date：2018-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 113-116,122 )